We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
JNJ.MX

Price
2863.72
Stock movement down
-21.28 (-0.74%)
Company name
Johnson & Johnson
Exchange
(MX
,
Currency
MXN
)
Sector
Healthcare >
Drug Manufacturers - General
Markedsværdi
6894.75B
Ent værdi
6982.90B
Pris/omsætning
78.62
Pris/bog
98.27
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
61.52%
Efterfølgende P/E
469.54
Fremtidig P/E
-
PEG
-
EPS-vekst
20.51%
1 års afkast
7.01%
3 års afkast
-6.38%
5 års afkast
-2.58%
10 års afkast
6.32%
Senest opdateret: 2025-06-22

UDBYTTE

JNJ.MX betaler ikke udbytte

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E469.54
Pris til OCF274.19
Pris til FCF362.40
Pris til EBITDA-
EV i forhold til EBITDA-

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning78.62
Pris til egenkapital98.27
EV i forhold til salg79.63

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier2.41B
EPS (TTM)6.10
FCF pr. aktie (TTM)7.90

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)87.70B
Bruttofortjeneste (TTM)60.55B
Driftsindkomst (TTM)22.82B
Nettoindkomst (TTM)14.68B
EPS (TTM)6.10
EPS (1 år frem)-

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)69.05%
Driftsmargin (TTM)26.02%
Fortjenstmargin (TTM)16.74%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter19.98B
Nettotilgodehavender16.17B
Omsætningsaktiver i alt53.25B
Goodwill44.80B
Immaterielle aktiver39.49B
Ejendomme, anlæg og udstyr49.27B
Sum aktiver178.29B
Kreditor8.95B
Kortfristet/nuværende langsigtet gæld0.00
Summen af kortfristede forpligtelser51.76B
Sum gæld108.13B
Aktionærernes egenkapital70.16B
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)25.15B
Investeringsudgifter (TTM)6.12B
Fri pengestrøm (TTM)19.02B
Udbetalt udbytte (TTM)11.70B

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast20.93%
Afkast af aktiver8.24%
Afkast af investeret kapital14.47%
Kontant afkast af investeret kapital18.75%

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning2880.01
Daglig høj2880.01
Daglig lav2856.33
Daglig volumen0K
Højeste gennem alle tider3874.99
1 års analytiker estimat-
Beta0.52
EPS (TTM)6.10
Udbytte pr. aktie-
Ex-div dato27 May 2025
Næste dato for resultatpræsentation16 Jul 2025

Nedsidepotensial

Loading...
Nedsidepotensial-data
JNJ.MXS&P500
Nuværende prisfald fra top notering-26.10%-3.04%
Højeste prisfald-37.07%-56.47%
Højeste efterår dato28 May 20249 Mar 2009
Gennemsnitlig fald fra toppen-9.80%-11.04%
Gennemsnitlig tid til nyt højdepunkt20 days12 days
Maks. tid til nyt højdepunkt1299 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
JNJ.MX (Johnson & Johnson) company logo
Markedsværdi
6894.75B
Markedsværdi kategori
Large-cap
Beskrivelse
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company has a collaboration agreement with Stand Up To Cancer for research testing a combination of teclistamab and daratumumab to treat a rare disease AL amyloidosis. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Personale
131900
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Mexico
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
The stock market faces a busy week with a packed Q2 launch, and Congress debating several pieces of crypto legislation.
13. juli 2025
Financials make up half of the 38 S&P 500 companies slated to report quarterly results this week. The week’s big economic news will be the consumer price index for June.
13. juli 2025
A busy week ahead for investors will see inflation data, the debate about the Fed's next move, and the start of second quarter earnings season all come into focus after a flurry of trade activity last...
13. juli 2025
Johnson & Johnson has delivered excellent returns to its long-term shareholders. Case in point: Shares of Johnson & Johnson (NYSE: JNJ), one of the world's largest healthcare companies, have increase...
13. juli 2025
Coming up: Big bank earnings, June CPI inflation data, and U.S. retail sales, along with updates from TSMC, Netflix and Johnson & Johnson.
13. juli 2025
We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer recently discussed. Johnson & Johnson (NYSE:J...
12. juli 2025
FDA Commissioner Marty Makary said the agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost of their medicines between the U.S. and other countries, Bloomberg’s Rache...
12. juli 2025
STORY: From a crucial U.S. inflation reading to GDP figures from China, these are the stories to watch in business and finance in the coming week.:: Look Ahead:: Tariff testJune’s consumer price index...
11. juli 2025
The pharmaceutical industry is staring down a major patent cliff, with key drugs from Merck (MRK), Bristol Myers Squibb (BMY), and Johnson & Johnson (JNJ) set to lose exclusivity by 2030. Yahoo Financ...
11. juli 2025
Pre-Markets Red on Trump's Tariff Threats to Canada.
11. juli 2025
Næste side